On Friday, OpenAI announced it will begin testing advertisements inside the ChatGPT app for some US users in a bid to expand its customer base and diversify revenue. The move represents a reversal for CEO Sam Altman, who in 2024 described advertising in ChatGPT as a "last resort" and expressed concerns that ads could erode user trust, although he did not completely rule out the possibility at the time.

The banner ads will appear in the coming weeks for logged-in users of the free version of ChatGPT as well as the new $8 per month ChatGPT Go plan, which OpenAI also announced Friday is now available worldwide. OpenAI first launched ChatGPT Go in India in August 2025 and has since rolled it out to over 170 countries.

Users paying for the more expensive Plus, Pro, Business, and Enterprise tiers will not see advertisements.

Read full article

Comments

On Wednesday, OpenAI announced ChatGPT Health, a dedicated section of the AI chatbot designed for "health and wellness conversations" intended to connect a user's health and medical records to the chatbot in a secure way.

But mixing generative AI technology like ChatGPT with health advice or analysis of any kind has been a controversial idea since the launch of the service in late 2022. Just days ago, SFGate published an investigation detailing how a 19-year-old California man died of a drug overdose in May 2025 after 18 months of seeking recreational drug advice from ChatGPT. It's a telling example of what can go wrong when chatbot guardrails fail during long conversations and people follow erroneous AI guidance.

Despite the known accuracy issues with AI chatbots, OpenAI's new Health feature will allow users to connect medical records and wellness apps like Apple Health and MyFitnessPal so that ChatGPT can provide personalized health responses like summarizing care instructions, preparing for doctor appointments, and understanding test results.

Read full article

Comments